Identification of prostate cancer modifier pathways using parental strain expression mapping

被引:11
作者
Xu, Qing
Majumder, Pradip K.
Ross, Kenneth
Shim, Yeonju
Golub, Todd R.
Loda, Massimo
Sellers, William R.
机构
[1] Novartis Inst Biomed Res, Cambridge, MA 02139 USA
[2] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Broad Inst, Cambridge, MA 02141 USA
[8] MIT, Cambridge, MA 02141 USA
关键词
glycolysis; proliferation;
D O I
10.1073/pnas.0708476104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
Inherited genetic risk factors play an important role in cancer. However, other than the Mendelian fashion cancer susceptibility genes found in familial cancer syndromes, little is known about risk modifiers that control individual susceptibility. Here we developed a strategy, parental strain expression mapping, that utilizes the homogeneity of inbred mice and genome-wide mRNA expression analyses to directly identify candidate germ-line modifier genes and pathways underlying phenotypic differences among murine strains exposed to transgenic activation of AKT1. We identified multiple candidate modifier pathways and, specifically, the glycolysis pathway as a candidate negative modulator of AKT1-induced proliferation. in keeping with the findings in the murine models, in multiple human prostate expression data set, we found that enrichment of glycolysis pathways in normal tissues was associated with decreased rates of cancer recurrence after prostatectomy. Together, these data suggest that parental strain expression mapping can directly identify germline modifier pathways of relevance to human disease.
引用
收藏
页码:17771 / 17776
页数:6
相关论文
共 25 条
[1]
The genetics and genomics of cancer [J].
Balmain, A ;
Gray, J ;
Ponder, B .
NATURE GENETICS, 2003, 33 (Suppl 3) :238-244
[2]
Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[3]
Chang YS, 2003, CLIN CANCER RES, V9, P3641
[4]
Haplotype-based genetics in mice and rats [J].
Cuppen, E .
TRENDS IN GENETICS, 2005, 21 (06) :318-322
[5]
Complexities in the genetic dissection of quantitative trait loci [J].
Darvasi, A ;
Pisanté-Shalom, A .
TRENDS IN GENETICS, 2002, 18 (10) :489-491
[6]
Strategies for mapping and cloning quantitative trait genes in rodents [J].
Flint, J ;
Valdar, W ;
Shifman, S ;
Mott, R .
NATURE REVIEWS GENETICS, 2005, 6 (04) :271-286
[7]
Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring [J].
Golub, TR ;
Slonim, DK ;
Tamayo, P ;
Huard, C ;
Gaasenbeek, M ;
Mesirov, JP ;
Coller, H ;
Loh, ML ;
Downing, JR ;
Caligiuri, MA ;
Bloomfield, CD ;
Lander, ES .
SCIENCE, 1999, 286 (5439) :531-537
[8]
A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer [J].
Lamb, J ;
Ramaswamy, S ;
Ford, HL ;
Contreras, B ;
Martinez, RV ;
Kittrell, FS ;
Zahnow, CA ;
Patterson, N ;
Golub, TR ;
Ewen, ME .
CELL, 2003, 114 (03) :323-334
[9]
MC1R germline variants confer risk for BRAF-mutant melanoma [J].
Landi, Maria Teresa ;
Bauer, Juergen ;
Pfeiffer, Ruth M. ;
Elder, David E. ;
Hulley, Benjamin ;
Minghetti, Paola ;
Calista, Donato ;
Kanetsky, Peter A. ;
Pinkel, Daniel ;
Bastian, Boris C. .
SCIENCE, 2006, 313 (5786) :521-522
[10]
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection [J].
Li, C ;
Wong, WH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :31-36